Etrasimod for elderly patients with ulcerative colitis
Part of Digestive system clinical trials.
This trial tests an oral medication called etrasimod for elderly patients with active ulcerative colitis. It aims to see if the drug is safe and effective in reducing inflammation and symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have active ulcerative colitis (UC) right now.
- You cannot have kidney failure (acute or chronic).
- You cannot have chronic heart disease or a lung infection.
- You cannot have liver cirrhosis, colorectal cancer, or an autoimmune disease.
- You cannot have an infectious disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to an investigational medicine called etrasimod for people with ulcerative colitis who have not been helped by at least three other treatments, or who cannot take them. It's a compassionate use program, meaning it's for patients with no other options.
This trial tests whether etrasimod can improve ulcerative colitis (UC) symptoms in adolescents with moderate to severe, active disease. It may help reduce inflammation and disease activity, especially if current treatments aren’t working well enough.
This study tests the drug etrasimod in people with active ulcerative colitis (UC). It looks at how well the drug works and its safety. If you have UC that is not well controlled, this trial might help you manage your condition.
This trial tests if the medicine etrasimod can help children with moderate to severe ulcerative colitis. You may still be able to join even if you are already taking other treatments for your condition.
This study watches how well etrasimod works for adults with moderate to severe ulcerative colitis (UC). You must already be prescribed etrasimod by your doctor, and the study collects information through a web-based tool.
This trial compares two oral medicines — etrasimod (a newer drug that works on the immune system) and mesalazine (a standard anti-inflammatory) — in Chinese adults with active ulcerative colitis. It aims to see which is better at controlling symptoms and is safer. If you have mild to moderate active UC, you may join.
Hear when a new Ulcerative Colitis (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.